BioPharma Credit PLC
BPCP.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £122 | £108 | £182 | £85 |
| Dep. & Amort. | £0 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | -£10 | -£9 | £8 | -£12 |
| Other Non-Cash | £0 | £24 | -£6 | £24 |
| Operating Cash Flow | £112 | £123 | £184 | £96 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | £0 | £0 | £0 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | -£37 | -£100 | -£187 |
| Inv. Sales/Matur. | £39 | £35 | £148 | £92 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | £39 | -£2 | £48 | -£95 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | -£106 | -£17 | -£50 | £0 |
| Dividends Paid | -£175 | -£90 | -£157 | -£100 |
| Other Fin. Act. | £0 | £0 | £0 | £0 |
| Financing Cash Flow | -£280 | -£107 | -£207 | -£100 |
| Forex Effect | -£0 | -£0 | -£0 | -£0 |
| Net Chg. in Cash | -£129 | £15 | £26 | -£99 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £135 | £121 | £95 | £193 |
| End Cash | £6 | £135 | £121 | £95 |
| Free Cash Flow | £112 | £123 | £184 | £96 |